Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Soluble fractalkine in the plasma of fibromyalgia patients.

Garcia JJ, Ortega E.

An Acad Bras Cienc. 2014 Dec;86(4):1915-7. doi: 10.1590/0001-3765201420130081. Epub 2014 Dec 9.

2.

Soluble fractalkine in the plasma of fibromyalgia patients.

Garcia JJ, Ortega E.

An Acad Bras Cienc. 2014 Dec 9;0:0. [Epub ahead of print]

3.

Fractalkine and TGF-beta1 levels reflect the severity of chronic pancreatitis in humans.

Yasuda M, Ito T, Oono T, Kawabe K, Kaku T, Igarashi H, Nakamura T, Takayanagi R.

World J Gastroenterol. 2008 Nov 14;14(42):6488-95.

4.

Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.

Kim TS, Lim HK, Lee JY, Kim DJ, Park S, Lee C, Lee CU.

Neurosci Lett. 2008 May 9;436(2):196-200. doi: 10.1016/j.neulet.2008.03.019. Epub 2008 Mar 13.

PMID:
18378084
5.

Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects.

Maegdefessel L, Schlitt A, Pippig S, Schwaab B, Fingscheidt K, Raaz U, Buerke M, Loppnow H.

Vasc Health Risk Manag. 2009;5:849-57. Epub 2009 Oct 12.

6.

Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity.

Suzuki F, Kubota T, Miyazaki Y, Ishikawa K, Ebisawa M, Hirohata S, Ogura T, Mizusawa H, Imai T, Miyasaka N, Nanki T.

Arthritis Res Ther. 2012 Mar 6;14(2):R48. doi: 10.1186/ar3761.

7.

Serum fractalkine and interferon-gamma inducible protein-10 concentrations are early detection markers for acute renal allograft rejection.

Zhang Q, Liu YF, Su ZX, Shi LP, Chen YH.

Transplant Proc. 2014 Jun;46(5):1420-5. doi: 10.1016/j.transproceed.2014.02.019.

PMID:
24935307
9.

Fractalkine is an independent predictor of mortality in patients with advanced heart failure.

Richter B, Koller L, Hohensinner PJ, Rychli K, Zorn G, Goliasch G, Berger R, Mörtl D, Maurer G, Huber K, Pacher R, Wojta J, Hülsmann M, Niessner A.

Thromb Haemost. 2012 Dec;108(6):1220-7. doi: 10.1160/TH12-03-0195. Epub 2012 Sep 26.

PMID:
23014777
10.

Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: a preliminary report.

Yao K, Lu H, Huang R, Zhang S, Hong X, Shi H, Sun A, Qian J, Zou Y, Ge J.

Cardiovasc Diabetol. 2011 Jun 10;10:50. doi: 10.1186/1475-2840-10-50.

11.

Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris.

Ikejima H, Imanishi T, Tsujioka H, Kashiwagi M, Kuroi A, Tanimoto T, Kitabata H, Ishibashi K, Komukai K, Takeshita T, Akasaka T.

Circ J. 2010 Feb;74(2):337-45. Epub 2009 Dec 17.

12.

Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients.

Hoogendijk AJ, Wiewel MA, van Vught LA, Scicluna BP, Belkasim-Bohoudi H, Horn J, Zwinderman AH, Klein Klouwenberg PM, Cremer OL, Bonten MJ, Schultz MJ, van der Poll T; MARS consortium.

Crit Care. 2015 Nov 25;19:412. doi: 10.1186/s13054-015-1125-0.

13.
14.

Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation.

Fevang B, Yndestad A, Damås JK, Bjerkeli V, Ueland T, Holm AM, Beiske K, Aukrust P, Frøland SS.

Clin Immunol. 2009 Feb;130(2):151-61. doi: 10.1016/j.clim.2008.09.002. Epub 2008 Oct 19.

PMID:
18938112
15.

Serum levels of fractalkine are associated with markers of insulin resistance in gestational diabetes.

Ebert T, Hindricks J, Kralisch S, Lossner U, Jessnitzer B, Richter J, Blüher M, Stumvoll M, Fasshauer M.

Diabet Med. 2014 Aug;31(8):1014-7. doi: 10.1111/dme.12451. Epub 2014 Apr 16.

PMID:
24673545
16.

Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis.

Blaschke S, Koziolek M, Schwarz A, Benöhr P, Middel P, Schwarz G, Hummel KM, Müller GA.

J Rheumatol. 2003 Sep;30(9):1918-27.

PMID:
12966591
17.

Circulating human fractalkine is decreased post-operatively after orthopedic and coronary bypass surgery.

Akerfeldt T, Helmersson-Karlqvist J, Gordh T, Larsson A.

In Vivo. 2014 Mar-Apr;28(2):185-8.

PMID:
24632971
18.

Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.

Brand S, Hofbauer K, Dambacher J, Schnitzler F, Staudinger T, Pfennig S, Seiderer J, Tillack C, Konrad A, Göke B, Ochsenkühn T, Lohse P.

Am J Gastroenterol. 2006 Jan;101(1):99-106.

PMID:
16405540
19.

CX(3)C chemokine fractalkine in pulmonary arterial hypertension.

Balabanian K, Foussat A, Dorfmüller P, Durand-Gasselin I, Capel F, Bouchet-Delbos L, Portier A, Marfaing-Koka A, Krzysiek R, Rimaniol AC, Simonneau G, Emilie D, Humbert M.

Am J Respir Crit Care Med. 2002 May 15;165(10):1419-25.

PMID:
12016106
20.

Altered profile of chemokines in fibromyalgia patients.

García JJ, Cidoncha A, Bote ME, Hinchado MD, Ortega E.

Ann Clin Biochem. 2014 Sep;51(Pt 5):576-81. doi: 10.1177/0004563213506413. Epub 2013 Oct 8.

PMID:
24106344

Supplemental Content

Support Center